Company / Current Liabilities
Day One Biopharmaceuticals, Inc. Current Liabilities History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$60.5M
FY2025
5-year range
$8.7M / $73.5M
FY2021-FY2025
Trend
-17.6%
vs FY2024
Sector context
#132 of 215
Health Care
What the data says
At $61M, Day One Biopharmaceuticals, Inc.'s current liabilities ranks #84 of 215 in the Health Care sector. Increased from $30M to $61M over the past 2 years.
Based on SEC 10-K filings.
$61M in FY2025 with a 5-year CAGR of +97.9%.
Increased from $30M to $61M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +53.9%
- 5-Year CAGR
- +97.9%
- 10-Year CAGR
- -
Sector benchmark
#84 of 215 in Health CareTop 39% of 215This company $60.5M Sector average $1.6B
▼
-96.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +97.9%, indicating consistent growth.
- In FY2025, current liabilities decreased 17.6% year-over-year.
- Ranks #132 out of 215 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $60.5M | -17.6% |
| FY2024 | $73.5M | +148.9% |
| FY2023 | $29.5M | +77.6% |
| FY2022 | $16.6M | +91.9% |
| FY2021 | $8.7M | +333.7% |
| FY2020 | $2.0M | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026